CEO and Founder of @M_Disrupt, Healthcare Executive #Genomics #DigitalHealth expert, ex VP Commercial Marketing @23andme, advisor, mentor.
Austin, TX
Joined December 2009
- Tweets20.3K
- Following7.2K
- Followers10.1K
- Likes5.1K
Lord, give me the confidence of a first time YC founder building in healthcare, who thinks their GTM is taking physicians out for dinner and has clearly never heard of the Sunshine act or the Stark law.
Ruby Gadelrab retweeted
I think one of the highest other predictors of entrepreneurial success is actually your spouse - ngmi if your spouse isn't all-in too
Blast from the past - how @m_disrupt started
My latest column is on two female execs who are starting a new “medical diligence” consulting firm to avert the next Theranos before it happens cnbc.com/2019/08/11/mdisrupt…
Ruby Gadelrab retweeted
Founders in healthcare need to be data and evidence driven and stop posting bad clinical takes for the clicks. Deciding to become a healthcare founder comes with a higher bar and responsibility. Thank you for your attention to this matter.
Ruby Gadelrab retweeted
This is even more important for #healthtech founders today than it was in 2023.
Payors are inundated with digital health opportunities,
- figure out who is NOT your target as well as who IS your target.
- need to understand payors CURRENT priorities
- target your solutions to the local demographics
@BenErsing @m_disrupt payor webinar
Ruby Gadelrab retweeted
Texas 10-year-old develops AI glasses to assist visually impaired children - kvue.com/article/news/local/… via @DivaBiotech
My 10 year old son just won his science fair building AI computer vision text to speech glasses for visually impaired children.
He then went on to write to the CEO of an EEG company so that he can improve the product by doing brainwave control. The CEO agreed to sponsor it.
Now he wants to talk to @elonmusk about it so we are shooting our shot! How can he contact Elon about his project?
MDisrupt Introduces Health Expert in the Loop to Put Clinicians at the Center of AI Training and Validation - businesswire.com/news/home/2…
Turned off my computer on Christmas Eve and turned it on again today.
This is my inbox.
I'm doing something wrong.
Apparently folks at #Aha2025 love our @m_disrupt giveaway... we will have more tomorrow
If you are at #AHA2025 I will be interviewing Dr Shami Feinglass at HIP at 9.30am on Monday to discuss clinicians and their roles with industry and she will also be doing a book signing of her book at the @m_disrupt booth
Pinch me moments.
When I started @m_disrupt six years ago, never in my wildest dreams did I imagine that we would build a company that would collaborate with the American Heart Association to welcome their members onto our platform.
Yet here we are at the AHA 2025 Sessions meeting in New Orleans getting ready to meet and welcome their Clincians, Scientists and industry leaders to MDisrupt to connect them with companies in industry who are innovating in heart and brain health.
As always this is personal: my dad and his siblings have all suffered from heart conditions. So this one is dedicated to my dad Ragai Gadelrab who thanks to the incredible innovation in heart health is still practicing orthopedic surgery in his 70s.
How A Healthcare Expert Network Is Powering Startup Growth forbes.com/sites/geristengel…
Ruby Gadelrab retweeted
Health tech founders have truly no idea how many AI solutions health systems are being pitched right now. It's approaching nearly a full time job just fielding the emails. Also this is literally day 2 for me at a health system.
Ruby Gadelrab retweeted
🧬 This Austin Bio & Health Roundup covers the last few weeks, with summer and vacations slowing me down, but not the ecosystem. 🧬
💰 Funding & Capital Signals
@GametoGen, a biotech developing stem cell-based therapies, raised $44M Series C to complete its Phase 3 infertility trial and pursue global approvals.
Shattuck Labs raised $103M in a private placement to advance Phase 2 clinical trials in inflammatory bowel disease.
@MaxwellBiosci closed a $20M round to accelerate R&D and clinical trial programs.
🚀 Launches, Expansions, Milestones & Wins
@AlafairBio received two FDA 510(k) clearances for its VersaCoat Tendon Protector and VersaCoat Nerve Protector.
@Oracle launched an AI-driven EHR for ambulatory providers, integrating voice interaction and AI agents.
@m_disrupt introduced “Health Expert Hourly,” offering instant access to healthcare decision makers via its new AI-enabled platform.
📊 Data
Hamza Shad of @cartainc broke down VC funding by sector& state. Texas had 23.7% of funding going towards Bio & Health (Biopharma + Med Devices + Healthtech) & was the 2nd least concentrated in the sector.
PA: 75.7%
MA: 59.5%
VA: 41.5%
NY: 30%
IL: 29.8%
CO: 27.1%
FL: 24.9%
CA: 23.9%
TX: 23.7% 🤠
WA: 22.3%
Some states are far more concentrated than I expected, though Massachusetts was no surprise.
🔬 Research & Medical Advancements
@phantom_neuro published findings from its ASCENT study in Prosthesis MDPI, assessing gesture accuracy for a multi-electrode EMG sensor array controlling neurotech prostheses.
💡Insights from Local Builders & Innovators
@SebastianCaliri of @8vc argued that “AI doctors won’t work for free,” emphasizing that business model innovation is as crucial as technical pr2ogress in health AI.
@iamjohnmackey joined @drmarkhyman's podcast, spotlighting Austin as a hub for consumer health, with Love Life and @function leading the way.
🤠 Texas Bio Triangle
San Antonio:@CizzleBio announced a JAMA Surgery study validating its DexG2 blood test for early detection of gastric cancer, highlighting the city’s role in advancing diagnostics.
Which development this round do you think shifts the Austin Bio & Health narrative most and why?
What’s Next? 🤠 🚀 🦾 🧬
